Crigler Najjar Syndrome: Clinical Trials

4 trials for Crigler Najjar Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Crigler Najjar Syndrome: new trials by email Literature Review of Crigler Najjar Syndrome trials Research Report on Crigler Najjar Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
Arm1 homemade phototherapy treatment, DRAP - Crigler Najjar Syndrome, Children
Not applicableUnknownAssistance Publique - Hôpitaux de Paris62014-12-012017-09-12
Immunity Against AAV in Crigler Najjar Patient
Blood sample for immunology - Crigler Najjar Syndrome
CompletedGenethon492014-11-012017-12-13
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)
Urea Cycle Disorders, Crigler Najjar Syndrome
CompletedCellaion SA92013-03-012019-05-28
Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
HepaStem - Urea Cycle Disorders, Crigler Najjar Syndrome
Phase 1 / Phase 2CompletedCellaion SA202012-03-012020-10-19

Narrower conditions

Crigler-Najjar Syndrome (4)  ·  Urea Cycle Disorders, Inborn (2)  ·  Rare Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hyperbilirubinemia, Hereditary (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Blood Specimen Collection (1)

Sponsors

Cellaion SA (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Genethon (1)

Countries

France (3)  ·  Belgium (2)  ·  Israel (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Dries Dobbelaere, MD/Prof (1)  ·  Giuliano Torre, MD (1)  ·  Hanna Mandel, MD (1)  ·  Stephanie Grunewald, MD (1)

Results publications

PMID 32028991